Grace Therapeutics, Inc. · NASDAQ:GRCE

Opaleye Management Inc. reported a 13.07% stake in Grace Therapeutics, Inc. (Schedule 13G)

Event Aug 5, 2026 · Filed Aug 7, 2026

Opaleye Management Inc. reported a 13.07% stake in Grace Therapeutics, Inc., 2,748,392 shares, as a passive investor on Aug 5, 2026. Filed Aug 7, 2026 (Schedule 13G).

Stake
13.07%
Shares
2,748,392
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Opaleye Management Inc.13.07%2,748,392
Opaleye, L.P.13.07%2,748,392
James Silverman13.07%2,748,392

Source

View original at SEC

Related